Featured News
November 26, 2024
Dr. Katalin Karikó, 2023 Nobel Laureate in Physiology or Medicine, received The Wistar Institute’s 2024 Helen Dean King Award and as a part of the day-long activities, Dr. Karikó spent time with Wi…
November 21, 2024
For Pancreatic Cancer Awareness Month, we sat down with Rahul S. Shinde, D.V.M., Ph.D., assistant professor in Wistar’s Ellen and Ronald Caplan Cancer Center who researches potential new therapies …
October 31, 2024
Infectious disease specialist & senior scientist in Wistar’s Lieberman lab, Dr. Soldan studies the connection between M.S. and Epstein Barr Virus. She is most intrigued with how the body respon…
October 29, 2024
Paul M. Lieberman, Ph.D., is leader of the Genome Regulation and Cell Signaling Program at the Ellen and Ronald Caplan Cancer Center. He studies how certain viruses, such as Epstein-Barr virus, est…
October 9, 2024
In July 2024, Jozef Madzo, Ph.D., joined Wistar’s faculty as an assistant professor and new director of the Bioinformatics Core Facility, which provides investigators with critical data analysis su…
October 8, 2024
In front of the 200-plus audience gathered in The Wistar Institute’s standing-room-only Sarah and Matthew Caplan Auditorium — as well as many more tuning in virtually — the 2023 Nobel Laureate in P…
September 30, 2024
The Wistar Institute celebrated the most successful fundraising campaign in its history with an evening reception at the Philadelphia Museum of Art. Donors, board members and Wistar staff gathered …
September 26, 2024
For 25 years Wistar has led the way in training students both locally and internationally for careers in the life science sector. The origins of Wistar’s commitment to training started with Dr. Wil…
September 12, 2024
On September 14th, 2014, The Robert and Penny Fox Tower at The Wistar Institute was opened, marking a monumental change in the look and biomedical research capacity of the Institute. This September…
September 3, 2024
Upon the launch of The Wistar Institute’s new Genome Regulation and Cell Signaling Program, we sat down with the Program’s leader — Hilary Koprowski, M.D., Endowed Professor Paul M. Lieberman, Ph.D…